Clear Search

Showing 1 result for “Zhang S”.

September 2023

Sécurité cardiovasculaire des inhibiteurs de Janus Kinase chez les patients atteints de polyarthrite rhumatoïde : Revue systématique et méta-analyse en réseau

Front Pharmacol. 2023; 8(14):1237234 doi 10.3389/fphar.2023.1237234

This meta-analysis by Wei, et al. found that JAKi therapy was not associated with a higher risk of MACE than treatment with adalimumab, abatacept, or placebo. However, a higher incidence of all-cause mortality was observed with tofacitinib treatment than with adalimumab treatment.